Effects of lactobacillus rhamnosus strain gg in pediatric obesity-related liver disease

Pietro Vajro, Claudia Mandato, Maria Rosaria Licenziati, Adriana Franzese, Dino Franco Vitale, Selvaggia Lenta, Maria Caropreso, Gianfranco Vallone, Rosaria Meli

Research output: Contribution to journalArticle

Abstract

Objective: Various lines of evidence suggest that malfunctioning of the gut-liver axis contributes to hepatic damage of rodents and humans with nonalcoholic fatty liver disease. We evaluated the effects of short-term probiotic treatment in children with obesity-related liver disease who were noncompliant with lifestyle interventions. Patients and Methods: Twenty obese children (age 10.7 ± 2.1 years) with persisting hypertransaminasemia and ultrasonographic (US) bright liver were enrolled in this double-blind, placebo-controlled pilot study. At baseline, patients underwent clinical and laboratory anthropometric evaluation, measurement of the US hepatorenal ratio, standard liver function tests, oral glucose tolerance test, serum tumor necrosis factor-alpha, the glucose hydrogen breath test, and evaluation of serum antibodies to antipeptidoglycan-polysaccharide polymers. After exclusion of causes of liver disease other than obesity, patients received either probiotic Lactobacillus rhamnosus strain GG (12 billion CFU/day) or placebo for 8 weeks. Results: Multivariate analysis after probiotic treatment revealed a significant decrease in alanine aminotransferase (average variation vs placebo P = 0.03) and in antipeptidoglycan-polysaccharide antibodies (average variation vs placebo P = 0.03) irrespective of changes in BMI z score and visceral fat. Tumor necrosis factor-alpha, and US bright liver parameters remained fairly stable. Conclusions: Probiotic L rhamnosus strain GG warrants consideration as a therapeutic tool to treat hypertransaminasemia in hepatopathic obese children noncompliant with lifestyle interventions.

Original languageEnglish
Pages (from-to)740-743
Number of pages4
JournalJournal of Pediatric Gastroenterology and Nutrition
Volume52
Issue number6
DOIs
Publication statusPublished - Jun 2011

    Fingerprint

Keywords

  • Children
  • Lactobacillus GG
  • liver
  • nonalcoholic fatty liver disease
  • probiotics

ASJC Scopus subject areas

  • Gastroenterology
  • Pediatrics, Perinatology, and Child Health

Cite this

Vajro, P., Mandato, C., Licenziati, M. R., Franzese, A., Vitale, D. F., Lenta, S., Caropreso, M., Vallone, G., & Meli, R. (2011). Effects of lactobacillus rhamnosus strain gg in pediatric obesity-related liver disease. Journal of Pediatric Gastroenterology and Nutrition, 52(6), 740-743. https://doi.org/10.1097/MPG.0b013e31821f9b85